tiprankstipranks
Advertisement
Advertisement

JP:4569 Stock Latest News

KYORIN Pharmaceutical Keeps Annual Dividend Steady at ¥57 Per Share
Company AnnouncementsKYORIN Pharmaceutical Keeps Annual Dividend Steady at ¥57 Per Share
11d ago
4569
KYORIN Expands Performance-Linked Stock Compensation Plan to Corporate Officers
PremiumCompany Announcements
KYORIN Expands Performance-Linked Stock Compensation Plan to Corporate Officers
19d ago
4569
KYORIN Pharmaceutical Reshapes Board and Audit Team in June Leadership Overhaul
PremiumCompany Announcements
KYORIN Pharmaceutical Reshapes Board and Audit Team in June Leadership Overhaul
19d ago
4569
KYORIN Sets Aggressive Investment Plan in New Medium-Term Strategy “Vision 110 – Stage 2 –”
PremiumCompany Announcements
KYORIN Sets Aggressive Investment Plan in New Medium-Term Strategy “Vision 110 – Stage 2 –”
19d ago
4569
KYORIN Pharmaceutical Misses Interim Profit Forecasts on Weaker Sales and Higher R&D Costs
PremiumCompany Announcements
KYORIN Pharmaceutical Misses Interim Profit Forecasts on Weaker Sales and Higher R&D Costs
19d ago
4569
KYORIN Pharmaceutical Announces Consolidated Results and Outlook for FY2025
PremiumCompany AnnouncementsKYORIN Pharmaceutical Announces Consolidated Results and Outlook for FY2025
19d ago
4569
Kyorin Pharmaceutical Slashes Profit Outlook and Plans Dividend Cut After Sharp Earnings Decline
Premium
Company Announcements
Kyorin Pharmaceutical Slashes Profit Outlook and Plans Dividend Cut After Sharp Earnings Decline
19d ago
4569
Kyorin to Transfer Generic Drug Operations to Co-Creation Platform with Daito
Premium
Company Announcements
Kyorin to Transfer Generic Drug Operations to Co-Creation Platform with Daito
1M ago
4569
KYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
PremiumCompany Announcements
KYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
2M ago
4569
KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO
PremiumCompany Announcements
KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO
2M ago
4569
Kyorin Pharma Overhauls Governance With New Mandate-Based Officer System
PremiumCompany Announcements
Kyorin Pharma Overhauls Governance With New Mandate-Based Officer System
3M ago
4569
KYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit
PremiumCompany Announcements
KYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit
4M ago
4569
KYORIN Pharma Releases Nine-Month Consolidated Results and Outlook
PremiumCompany AnnouncementsKYORIN Pharma Releases Nine-Month Consolidated Results and Outlook
4M ago
4569
KYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
Premium
Company Announcements
KYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
4M ago
4569
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
Premium
Company Announcements
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
5M ago
4569
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
PremiumCompany Announcements
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
7M ago
4569
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
PremiumCompany Announcements
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
8M ago
4569
KYORIN Pharma Announces Phase 3 Study Results for Pulmonary Sarcoidosis Treatment
PremiumCompany Announcements
KYORIN Pharma Announces Phase 3 Study Results for Pulmonary Sarcoidosis Treatment
9M ago
4569
KYORIN Pharmaceutical Reports Strong Quarterly Growth Amidst Challenging Full-Year Outlook
PremiumCompany Announcements
KYORIN Pharmaceutical Reports Strong Quarterly Growth Amidst Challenging Full-Year Outlook
10M ago
4569
KYORIN Pharmaceutical Announces Dividend Distribution
PremiumCompany AnnouncementsKYORIN Pharmaceutical Announces Dividend Distribution
1y ago
4569
KYORIN Pharmaceutical Announces Executive Personnel Changes
Premium
Company Announcements
KYORIN Pharmaceutical Announces Executive Personnel Changes
1y ago
4569
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
Premium
Company Announcements
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
1y ago
4569

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >